In A First, Kerala Drugs Control Dept Files Complaint Against Divya Pharmacy In Kozhikode Court

Kozhikode: After the Supreme Court, yoga and ayurveda guru Baba Ramdev is set to face legal proceedings in Kerala over alleged misleading drug promotions. The Kerala government’s drugs control department is the first such state agency to file a case to prosecute Baba Ramdev and Divya Pharmacy he founded. He has been named third accused in the case, after the pharmacy and Acharya Balkrishna, chairman of Patanjali Ayurved. If convicted the duo could face a jail term of up to six months and a fine.

In its case, filed before the Judicial First Class Magistrate Court IV in Kozhikode, the department said that Divya Pharmacy had advertised pharmaceutical products that claimed to cure sexual impotence and diabetes. These are among the 54 diseases for which cure should not be advertised, under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Though the pharmacy has been repeatedly accused of violating drug laws, it eluded prosecution due to difficulties in filing cases. This time, however, the drugs regulator was emboldened by the Supreme Court’s intervention. Drugs controller Dr K Sujith Kumar ordered a statewide combing operation, involving 40 inspectors, to dig up violations. In Kozhikode region alone, 20 instances of violations were found, which forms the basis of the department case.

Shaji Varghese, the assistant drugs controller, sent a special team to Delhi to trace the people responsible for the advertisements. The case was initiated based on a complaint filed by Dr Babu K V, a health activist from Kannur.

“Repeated advertising by Patanjali, which involved even urging patients to stop taking insulin for type 1 diabetes and switch over to their products, can lead to a major public health crisis, with parents stopping insulin for children. I am certain the decisive intervention of the Supreme Court and prosecution by Kerala drug authorities will put an end to ongoing illegal advertising by Patanjali and other ayurveda companies,” said Dr Babu, who also played a decisive role in the case against Baba Ramdev in the SC.

Since 2022, he has filed over 100 RTI applications and complaints to halt alleged illegal drug promotions by Divya Pharmacy.

The Kerala government’s drugs control department is the first state agency to file a case to prosecute Baba Ramdev and Divya Pharmacy he founded. He has been named third accused in the case, after the pharmacy and Acharya Balkrishna, chairman of Patanjali Ayurved.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit